Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bombesin receptor-activated protein (BRAP) is a multifunctional protein encoded by the C6orf89 gene, serving as an enhancer of histone deacetylase activity to regulate chromatin remodeling, immune response, and cell proliferation. The protein exists as several isoforms that localize to the nucleolus, Golgi, and midbody, integrating into cellular structures associated with ribosome biogenesis, mitosis, and wound repair. BRAP modulates immune and inflammatory responses, particularly in airway epithelial cells, through HDAC-mediated suppression of NF-κB, influencing cell repair and immune surveillance. Dysregulation of BRAP is implicated in diseases including cancer, kidney injury, and congenital glycosylation disorders, where it shapes cell fate and drug response through epigenetic and transcriptional mechanisms
Enhancement of histone deacetylase (HDAC) activity; Suppression of NF-κB transcriptional activity; Regulation of ribosomal gene transcription; Modulation via effects on SIRT2 in kidney injury
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bombesin receptor-activated protein (BRAP).